Earnings Call · Q4 FY2024·2025-03-31

Q4 24EPS -28.83%·Rev n/aQ3 24EPS -67.19%·Rev n/aQ2 24EPS +47.73%·Rev n/aQ1 24EPS +21.24%·Rev n/a⚠ consensus missing

Bionano Genomics, Inc. BNGO

David Holmes — Investor Relations

Erik Holmlin — CEO and Principal Financial Officer

−4.5%1d on move date−4.7% vs SPY3d−4.5%5d−18.2%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BNGO calls or request research access.

More BNGO calls Browse calls Request research access